fbpx
LOADING

Type to search

Team Nigma Adds ILTW, Miracle Back as Midlaner?

Dethan Dario
Share

Seems like stars are starting to align for Nigma as ILTW gets signed to work as carry for the team.

Dota 2 News: ILTW parts ways with OG | GosuGamers

Nigma, who had recently axed w33ha after their early Singapore exit, beat their deadline of finalizing a roster by signing ILTW as carry for the team today, April 11.

The changes fulfill the team’s quest of replacing w33ha who has been placed in the inactive roster last April 6.

“New patch, new. We’re excited to announce @iLTW1 as our 5th player! Welcome to the squad Igor. #StarsAlign” the organization announced on their Twitter.

The team’s decision to move w33ha to the inactive roster comes after fans’ calls to replace the player as they are tagging him as the weak link as shown in their Singapore Major early exit.

However, the team’s performance can also be related to the quick change prior the tournament after Mind_Control tested positive of COVID which lead Kuroky and the squad to play without their veteran.

Mind Controlled : DotA2

ILTW has been on Virtus Pro’s inactive roster since the start of January, and has been fully relieved from the squad in February 17.

The former VP carry is now tasked to play a dual carry position with Miracle handing over Kuroky the edge of playing a bigger pool of heroes, and playstyles to work with.

Team Nigma benches w33 after finishing last in Singapore Major

W33 on the other hand is now the team’s sixth player. He is, however, given the option to explore more options with other teams although he only has until April 12 to look for other teams to catch up with roster lock deadlines.

With these massive changes, Ana’s comeback becomes more realistic as rumors and speculations before tag ILTW to be signing with OG as the carry.

In his signing with Nigma, the stars of Ana’s return may be aligning even better for OG.

Ana's most played heroes : DotA2

Follow Hyprgame on Facebook, Twitter, and Instagram for more updates!

Tags:

You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Next Up